Board of Trustees of The Leland Stanford Junior University’s ALX Oncology ALXO Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-259,982	Closed	-$14.2M	–	44
2021 Q2	$14.2M	Sell	259,982 -258,840	-50%	-$15.5M	1.33%	12
2021 Q1	$38.3M	Sell	518,822 -928,032	-64%	-$73M	3.38%	7
2020 Q4	$125M	Hold	1,446,854	–	–	8.79%	4
2020 Q3	$54.6M	Buy	+1,446,854	New	+$56.9M	21.04%	2

Other funds holding ALXO

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's ALXO Position: Q3 2021 in Review

Board of Trustees of The Leland Stanford Junior University sold out of ALX Oncology (ALXO) in Q3 2021, closing a stake of 259,982 shares — an estimated $14.2M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in ALXO in Q3 2020 and held it in 4 quarters. The position peaked at $125M in Q4 2020. 114 funds tracked by Wall St. Rank hold ALXO as of Q3 2021.

Board of Trustees of The Leland Stanford Junior University reported no remaining ALX Oncology position as of Q3 2021 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 259,982 ALX Oncology shares in Q3 2021, an estimated $14.2M.
Board of Trustees of The Leland Stanford Junior University first reported a position in ALX Oncology in Q3 2020 and held it in 4 quarters.
Board of Trustees of The Leland Stanford Junior University's ALX Oncology position peaked at $125M in Q4 2020.
114 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2021.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q3 2021, filed 12 Nov 2021.